Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 121

1.

C-Reactive Protein and Platelet-Lymphocyte Ratio as Potential Tumor Markers in Low-Alpha-Fetoprotein Hepatocellular Carcinoma.

Suner A, Carr BI, Akkiz H, Karakülah G, Üsküdar O, Yalçın K, Kuran S, Tokat Y, Yilmaz S, Özakyol A, Tokmak S, Ballı T, Yücesoy M, Bahçeci Hİ, Ülkü A, Akçam T, Polat KY, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Demir A, Delik A, Arslan B, Doran F, Altıntaş E, Temel T, Bektaş A.

Oncology. 2018 Oct 18:1-8. doi: 10.1159/000492473. [Epub ahead of print]

PMID:
30336489
2.

Incidentally detected PET-avid liver adenomatosis: MRI and 18F-FDG PET-CT findings.

Öz A, Koyuncu Sökmen B, İnan N, Balcı NC, Tokat Y.

Turk J Gastroenterol. 2018 Sep;29(5):623-624. doi: 10.5152/tjg.2018.17783. No abstract available.

PMID:
30260790
3.

International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.

Tsochatzis E, Coilly A, Nadalin S, Levistky J, Tokat Y, Ghobrial M, Klinck J, Berenguer M.

Transplantation. 2018 Aug 27. doi: 10.1097/TP.0000000000002433. [Epub ahead of print]

PMID:
30153225
4.

Macroscopic Portal Vein Thrombosis in HCC Patients.

Akkiz H, Carr BI, Kuran S, Karaoğullarından Ü, Üsküdar O, Tokmak S, Arslan B, Doran F, Balli HT, Ülkü A, Akçam TA, Bahçeci Hİ, Polat KY, Örmeci N, Şimşek H, Sonsuz A, Demir A, Altıntaş E, Demir M, Yalçın K, Ekinci N, Harmancı Özakyol A, Yücesoy M, Uygun A, Guerra V, Delik A, Tokat Y, Yilmaz S, Bektaş A, Kılıç M.

Can J Gastroenterol Hepatol. 2018 Jun 13;2018:3120185. doi: 10.1155/2018/3120185. eCollection 2018.

5.

C-reactive protein and hepatocellular carcinoma: analysis of its relationships to tumor factors.

Carr BI, Akkiz H, Guerra V, Üsküdar O, Kuran S, Karaoğullarından Ü, Tokmak S, Ballı T, Ülkü A, Akçam T, Delik A, Arslan B, Doran F, Yalçın K, Altntaş E, Özakyol A, Yücesoy M, Bahçeci Hİ, Polat KY, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Demir A, Yilmaz S, Tokat Y.

Clin Pract (Lond). 2018;15(Spec Issue):625-634. doi: 10.4172/clinical-practice.1000409.

6.

The predictive value of risk indices for cardiac complications in living donor liver transplantation.

Canbolat IP, Erdogan Y, Adali G, Kaplan O, Dayangac M, Yuzer Y, Tokat Y.

Bratisl Lek Listy. 2018;119(5):289-293. doi: 10.4149/BLL_2018_054.

PMID:
29749243
7.

HCC with low- and normal-serum alpha-fetoprotein levels.

Carr BI, Akkiz H, Üsküdar O, Yalçın K, Guerra V, Kuran S, Karaoğullarından Ü, Altıntaş E, Özakyol A, Tokmak S, Ballı T, Yücesoy M, Bahçeci Hİ, Ülkü A, Akçam T, Polat KY, Ekinci N, Şimşek H, Örmeci N, Sonsuz A, Demir M, Kılıç M, Uygun A, Demir A, Delik A, Arslan B, Doran F, Yilmaz S, Tokat Y.

Clin Pract (Lond). 2018;15(1):453-464. doi: 10.4172/clinical-practice.1000393.

8.

Diagnostic performances of intravoxel incoherent motion and conventional diffusion-weighted imaging in the differential diagnosis of benign and malignant portal vein thrombus.

Aumann EK, Server S, Koyuncu Sokmen B, Oz A, Namal E, Gurcan NI, Balci NC, Tokat Y.

Abdom Radiol (NY). 2018 Sep;43(9):2270-2276. doi: 10.1007/s00261-018-1467-6.

PMID:
29411058
9.

Living Donor Liver Transplantation.

Bozkurt B, Dayangac M, Tokat Y.

Chirurgia (Bucur). 2017 May-Jun;112(3):217-228. doi: 10.21614/chirurgia.112.3.217. Review.

10.

Liver Transplantation in a Patient with Acquired Dysfibrinogenemia Who Presented with Subdural Hematoma: A Case Report.

Acar Ş, Güngör G, Dayangaç M, Diz-Küçükkaya R, Tokat Y, Akyıldız M.

Turk J Haematol. 2017 Dec 1;34(4):356-357. doi: 10.4274/tjh.2017.0045. Epub 2016 Jun 7. No abstract available.

11.

Graft-to-recipient weight ratio threshold adjusted to the model for end-stage liver disease score for living donor liver transplantation.

Alim A, Erdogan Y, Yuzer Y, Tokat Y, Oezcelik A.

Liver Transpl. 2016 Dec;22(12):1643-1648. doi: 10.1002/lt.24523.

12.

Liver transplantation for homozygote familial hypercholesterolemia: the only curative treatment.

Alim A, Tokat Y, Erdogan Y, Gokkaya Z, Dayangac M, Yuzer Y, Oezcelik A.

Pediatr Transplant. 2016 Dec;20(8):1060-1064. doi: 10.1111/petr.12763. Epub 2016 Jul 20.

PMID:
27435024
13.

The long-term efficacy of combining nucleos(t)ide analog and low-dose hepatitis B immunoglobulin on post-transplant hepatitis B virus recurrence.

Idilman R, Akyildiz M, Keskin O, Gungor G, Yilmaz TU, Kalkan C, Dayangac M, Cinar K, Balci D, Hazinedaroglu S, Tokat Y.

Clin Transplant. 2016 Oct;30(10):1216-1221. doi: 10.1111/ctr.12804. Epub 2016 Aug 8.

PMID:
27409074
14.

The evolution of anterior sector venous drainage in right lobe living donor liver transplantation: does one technique fit all?

Dayangac M, Tokat Y.

Hepatobiliary Surg Nutr. 2016 Apr;5(2):151-8. doi: 10.3978/j.issn.2304-3881.2015.08.01. Review.

15.

Living Donor Liver Transplantation Outcomes for Hepatocellular Carcinoma Beyond Milan or UCSF Criteria.

Gunay Y, Guler N, Yaprak O, Dayangac M, Akyildiz M, Altaca G, Yuzer Y, Tokat Y.

Indian J Surg. 2015 Dec;77(Suppl 3):950-6. doi: 10.1007/s12262-014-1078-6. Epub 2014 Apr 24.

16.

Authors' reply.

Arat N, Akyıldız M, Tellioğlu G, Tokat Y.

Turk Kardiyol Dern Ars. 2015 Sep;43(6):586-7. doi: 10.5543/tkda.2015.. No abstract available.

17.

Living donor right lobe liver transplantation as a treatment for hepatic alveolar echinococcosis: report of three cases.

Demirbas T, Akyildiz M, Dayangac M, Yaprak O, Dogusoy G, Bassullu N, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2015 Jan-Feb;62(137):93-7.

PMID:
25911875
18.

Cardiac involvement of primary hyperoxaluria accompanied by non-compaction cardiomyopathy and patent ductus arteriosus.

Arat N, Akyıldız M, Tellioğlu G, Tokat Y.

Turk Kardiyol Dern Ars. 2015 Apr;43(3):288-91. doi: 10.5543/tkda.2015.46026.

19.

Major complications of adult right lobe living liver donors.

Guler N, Yaprak O, Gunay Y, Dayangac M, Akyildiz M, Yuzer F, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2015 Apr;14(2):150-6.

PMID:
25865687
20.

Living Donor Liver Transplantation in Patients 70 Years or Older.

Oezcelik A, Dayangac M, Guler N, Yaprak O, Erdogan Y, Akyildiz M, Sevdik Z, Yuzer Y, Tokat Y.

Transplantation. 2015 Jul;99(7):1436-40. doi: 10.1097/TP.0000000000000524.

PMID:
25606791
21.

Management of patients with recurrent hepatocellular carcinoma following living donor liver transplantation: a single center experience.

Gunay Y, Guler N, Akyildiz M, Yaprak O, Dayangac M, Yuzer Y, Tokat Y.

Gulf J Oncolog. 2014 Jan;1(15):12-8.

PMID:
24610283
22.

Glasgow coma scale and APACHE-II scores affect the liver transplantation outcomes in patients with acute liver failure.

Guler N, Unalp O, Guler A, Yaprak O, Dayangac M, Sozbilen M, Akyildiz M, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2013 Dec;12(6):589-93.

PMID:
24322743
23.

Anatomical variations of donor portal vein in right lobe living donor liver transplantation: the safe use of variant portal veins.

Guler N, Dayangac M, Yaprak O, Akyildiz M, Gunay Y, Taskesen F, Tabandeh B, Bulutcu F, Yuzer Y, Tokat Y.

Transpl Int. 2013 Dec;26(12):1191-7. doi: 10.1111/tri.12190. Epub 2013 Oct 15.

24.

Living donor liver transplantation for obese patients: challenges and outcomes.

Gunay Y, Guler N, Dayangac M, Taskesen F, Yaprak O, Emek E, Akyildiz M, Altaca G, Yuzer Y, Tokat Y.

Liver Transpl. 2014 Mar;20(3):311-22. doi: 10.1002/lt.23794. Epub 2014 Jan 13.

25.

Liver transplantation for fulminant hepatic failure due to iatrogenic porta hepatis injury.

Guler N, Gunay Y, Dayangac M, Yaprak O, Akyildiz M, Yuzer Y, Tokat Y.

Minerva Chir. 2013 Jun;68(3):333-4. No abstract available.

PMID:
23774100
26.

Successful treatment of severe hepatorenal syndrome with living donor liver transplantation.

Demirbas BT, Piskin T, Dayangac M, Yaprak O, Oklu L, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2012 Oct;59(119):2305-6. doi: 10.5754/hge10791.

PMID:
23435146
27.

Which incision is better for living-donor right hepatectomy? Midline, J-shaped, or Mercedes.

Demirbas T, Bulutcu F, Dayangac M, Yaprak O, Guler N, Oklu L, Akyildiz M, Altaca G, Tokat Y, Yuzer Y.

Transplant Proc. 2013 Jan-Feb;45(1):218-21. doi: 10.1016/j.transproceed.2012.06.081.

PMID:
23375303
28.

The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma.

Bassullu N, Turkmen I, Dayangac M, Yagiz Korkmaz P, Yasar R, Akyildiz M, Yaprak O, Tokat Y, Yuzer Y, Bulbul Dogusoy G.

Hepat Mon. 2012 Oct;12(10 HCC):e7492. doi: 10.5812/hepatmon.7492. Epub 2012 Oct 11.

29.

A new technique for the reconstruction of complex portal vein anomalies in right lobe living liver donors.

Yaprak O, Guler N, Balci NC, Dayangac M, Demirbas T, Killi R, Tokat Y, Yuzer Y.

Hepatobiliary Pancreat Dis Int. 2012 Aug 15;11(4):438-41.

PMID:
22893474
30.

AFP level and histologic differentiation predict the survival of patients with liver transplantation for hepatocellular carcinoma.

Yaprak O, Akyildiz M, Dayangac M, Demirbas BT, Guler N, Dogusoy GB, Yuzer Y, Tokat Y.

Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):256-61.

PMID:
22672818
31.

Ratio of remnant to total liver volume or remnant to body weight: which one is more predictive on donor outcomes?

Yaprak O, Guler N, Altaca G, Dayangac M, Demirbas T, Akyildiz M, Ulusoy L, Tokat Y, Yuzer Y.

HPB (Oxford). 2012 Jul;14(7):476-82. doi: 10.1111/j.1477-2574.2012.00483.x.

32.

Vascular complications in hepatic transplantation: single-center experience in 14 years.

Akun E, Yaprak O, Killi R, Balci NC, Tokat Y, Yuzer Y.

Transplant Proc. 2012 Jun;44(5):1368-72. doi: 10.1016/j.transproceed.2012.02.027.

PMID:
22664017
33.

Living-donor liver transplant in 3 patients with Budd-Chiari syndrome: case report.

Bas K, Yaprak O, Dayangac M, Ulusoy OL, Dogusoy GB, Yuzer Y, Tokat Y.

Exp Clin Transplant. 2012 Apr;10(2):172-5. doi: 10.6002/ect.2011.0044. Epub 2012 Jan 25.

34.

Right-lobe liver transplant from donors with Gilbert syndrome.

Demirbas T, Piskin T, Dayangac M, Yaprak O, Akyildiz M, Tokat Y, Yuzer Y.

Exp Clin Transplant. 2012 Feb;10(1):39-42.

35.

International collaboration of Turkey in liver transplantation research: a bibliometric analysis.

Bas K, Dayangac M, Yaprak O, Yuzer Y, Tokat Y.

Transplant Proc. 2011 Dec;43(10):3796-801. doi: 10.1016/j.transproceed.2011.09.081. Epub 2011 Nov 10.

PMID:
22172849
36.

Biliary complications after right lobe living donor liver transplantation: a single-centre experience.

Yaprak O, Dayangac M, Akyildiz M, Demirbas T, Guler N, Bulutcu F, Bassullu N, Akun E, Yuzer Y, Tokat Y.

HPB (Oxford). 2012 Jan;14(1):49-53. doi: 10.1111/j.1477-2574.2011.00401.x. Epub 2011 Oct 25.

37.

Recipient splenic artery utilization for arterial re-anastomosis in living donor liver transplantation: single-center experience.

Piskin T, Demirbas T, Yalcin L, Yaprak O, Dayangac M, Guler N, Bulutcu F, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2012 Jun;59(116):1263-4. doi: 10.5754/hge11642.

PMID:
22057376
38.

Living donor liver hilar variations: surgical approaches and implications.

Yaprak O, Demirbas T, Duran C, Dayangac M, Akyildiz M, Tokat Y, Yuzer Y.

Hepatobiliary Pancreat Dis Int. 2011 Oct;10(5):474-9.

PMID:
21947720
39.

General evaluation of hepatectomy and hepatocellular carcinoma cases.

Başsüllü N, Türkmen I, Yaprak O, Dayangaç M, Demırbaş T, Güler N, Uraz S, Akyildiz M, Cığercıoğullari E, Tokat Y, Yüzer Y, Doğusoy GB.

Turk Patoloji Derg. 2011;27(3):221-9. doi: 10.5146/tjpath.2011.01079.

40.

Cryopreserved aortic quilt plasty for one-step reconstruction of multiple hepatic venous drainage in right lobe living donor liver transplantation.

Yaprak O, Balci NC, Dayangac M, Demirbas T, Guler N, Ulusoy L, Tokat Y, Yuzer Y.

Transplant Proc. 2011 Sep;43(7):2817-9. doi: 10.1016/j.transproceed.2011.06.064.

PMID:
21911171
41.

Living donor liver transplantation for hepatocellular carcinoma: a single center analysis of outcomes and impact of different selection criteria.

Balci D, Dayangac M, Yaprak O, Akin B, Duran C, Killi R, Yuzer Y, Tokat Y.

Transpl Int. 2011 Nov;24(11):1075-83. doi: 10.1111/j.1432-2277.2011.01311.x. Epub 2011 Aug 19.

42.

Analysis of right lobe living-liver donor complications: a single center experience.

Yaprak O, Dayangac M, Demirbas BT, Tabendeh B, Yuzer Y, Tokat Y.

Exp Clin Transplant. 2011 Feb;9(1):56-9.

43.

Utilization of elderly donors in living donor liver transplantation: when more is less?

Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, Yuzer Y, Tokat Y.

Liver Transpl. 2011 May;17(5):548-55. doi: 10.1002/lt.22276.

44.

Use of livers from hepatitis B core antibody positive donors in living donor liver transplantation.

Yaprak O, Dayangac M, Balci D, Demirbas T, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1268-71.

PMID:
21410070
45.

Hepatitis B prophylaxis in living donor liver transplantation: single center experience.

Yaprak O, Dayangac M, Balci D, Bas K, Yuzer Y, Tokat Y.

Hepatogastroenterology. 2010 Sep-Oct;57(102-103):1178-82.

PMID:
21410054
46.

Dual left lobe living donor liver transplantation using donors unacceptable for right lobe donation: a case report.

Dayangac M, Taner CB, Akin B, Uraz S, Balci D, Duran C, Ayanoglu O, Killi R, Yuzer Y, Tokat Y.

Transplant Proc. 2010 Dec;42(10):4560-3. doi: 10.1016/j.transproceed.2010.09.149.

PMID:
21168737
47.

Characterization of frequency-dependent material properties of human liver and its pathologies using an impact hammer.

Umut Ozcan M, Ocal S, Basdogan C, Dogusoy G, Tokat Y.

Med Image Anal. 2011 Feb;15(1):45-52. doi: 10.1016/j.media.2010.06.010. Epub 2010 Jul 1.

PMID:
20655273
48.

Use of middle hepatic vein in right lobe living donor liver transplantation.

Dayangac M, Taner CB, Balci D, Memi I, Yaprak O, Akin B, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y.

Transpl Int. 2010 Mar 1;23(3):285-91. doi: 10.1111/j.1432-2277.2009.00978.x. Epub 2009 Oct 12.

49.

Hepatic arterial mapping by multidetector computed tomographic angiography in living donor liver transplantation.

Duran C, Uraz S, Kantarci M, Ozturk E, Doganay S, Dayangac M, Bozkurt M, Yuzer Y, Tokat Y.

J Comput Assist Tomogr. 2009 Jul-Aug;33(4):618-25. doi: 10.1097/RCT.0b013e31818d814b.

PMID:
19638861
50.

Donor safety and remnant liver volume in living donor liver transplantation.

Taner CB, Dayangac M, Akin B, Balci D, Uraz S, Duran C, Killi R, Ayanoglu O, Yuzer Y, Tokat Y.

Liver Transpl. 2008 Aug;14(8):1174-9. doi: 10.1002/lt.21562.

Supplemental Content

Support Center